Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $1,009 - $1,116
6 Added 0.1%
5,726 $1.02 Million
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $90,456 - $102,725
-572 Reduced 9.09%
5,720 $1.01 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $57,978 - $64,429
-359 Reduced 5.4%
6,292 $1.02 Million
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $9,409 - $10,093
-59 Reduced 0.88%
6,651 $1.1 Million
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $153,529 - $170,991
1,003 Added 17.57%
6,710 $1.1 Million
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $197,849 - $227,099
-1,443 Reduced 20.18%
5,707 $898,000
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $23,022 - $25,228
-164 Reduced 2.24%
7,150 $1.06 Million
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $1,159 - $1,399
-9 Reduced 0.12%
7,314 $1.03 Million
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $95,691 - $132,585
861 Added 13.32%
7,323 $960,000
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $9,562 - $10,983
-75 Reduced 1.15%
6,462 $943,000
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $209,053 - $229,918
-1,594 Reduced 19.6%
6,537 $910,000
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $125 - $139
1 Added 0.01%
8,131 $1.14 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $257,964 - $310,464
-2,100 Reduced 20.53%
8,130 $1.05 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $8,510 - $10,001
-70 Reduced 0.68%
10,230 $1.41 Million
Q2 2018

Aug 13, 2018

SELL
$119.4 - $131.76 $893,947 - $986,487
-7,487 Reduced 42.09%
10,300 $1.25 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $8,256 - $9,777
66 Added 0.37%
17,787 $2.28 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $91,591 - $100,246
-698 Reduced 3.79%
17,721 $2.48 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $2.38 Million - $2.49 Million
18,419
18,419 $2.4 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ativo Capital Management LLC Portfolio

Follow Ativo Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ativo Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ativo Capital Management LLC with notifications on news.